Diethylaniline

Diethylaniline

SCHEMBL3781396

CCN(CC)c1ccccc1.OBO

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.59
CNR2 P34972 2/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
NOX1 Q9Y5S8 1/20 0.53
ALDH1A1 P00352 5/20 0.52
CYP3A4 P08684 2/20 0.52
GLA P06280 1/20 0.48
TDP1 Q9NUW8 2/20 0.48
PSMD14 O00487 1/20 0.48
MAPK1 P28482 1/20 0.48
RECQL P46063 1/20 0.48
GFER P55789 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH3A1 P30838 1/20 0.45
ALDH1A3 P47895 1/20 0.45
HSD11B1 P28845 1/20 0.45
TAAR1 Q96RJ0 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylaniline SCHEMBL10699604 0.90 TSHR (0.64) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL17594 0.90 TSHR (0.70) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL9000098 0.90 TSHR (0.70) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL11443667 0.88 TSHR (0.61) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL28100873 0.88 TSHR (0.61) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL30880867 0.87 TSHR (0.67) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL31229134 0.87 TSHR (0.67) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL184484 0.87 TSHR (0.67) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL1920410 0.87 TSHR (0.67) TSHRCNR2MEN1KMT2ARAB9A
Diethylaniline SCHEMBL2215318 0.87 TSHR (0.67) TSHRCNR2MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024016826-A1 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF 杭州市第七人民医院 2024-01-25 WO claimed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 TSHR 1688/4885CNR2 1524/4885MEN1 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.